IQVIA Holdings Inc. (IQV)
NYSE: IQV · IEX Real-Time Price · USD
224.57
-0.28 (-0.12%)
At close: Jul 19, 2024, 4:00 PM
235.00
+10.43 (4.64%)
Pre-market: Jul 22, 2024, 7:40 AM EDT
IQVIA Holdings Revenue
IQVIA Holdings had revenue of $15.07B in the twelve months ending March 31, 2024, with 3.97% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $3.74B with 2.33% year-over-year growth. In the year 2023, IQVIA Holdings had annual revenue of $14.98B with 3.98% growth.
Revenue (ttm)
$15.07B
Revenue Growth
+3.97%
P/S Ratio
2.72
Revenue / Employee
$173,207
Employees
87,000
Market Cap
40.92B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 14.98B | 574.00M | 3.98% |
Dec 31, 2022 | 14.41B | 536.00M | 3.86% |
Dec 31, 2021 | 13.87B | 2.52B | 22.14% |
Dec 31, 2020 | 11.36B | 271.00M | 2.44% |
Dec 31, 2019 | 11.09B | 676.00M | 6.49% |
Dec 31, 2018 | 10.41B | 710.00M | 7.32% |
Dec 31, 2017 | 9.70B | 2.89B | 42.36% |
Dec 31, 2016 | 6.82B | 1.08B | 18.79% |
Dec 31, 2015 | 5.74B | 277.00M | 5.07% |
Dec 31, 2014 | 5.46B | 360.46M | 7.07% |
Dec 31, 2013 | 5.10B | 234.03M | 4.81% |
Dec 31, 2012 | 4.87B | 537.77M | 12.43% |
Dec 31, 2011 | 4.33B | 403.73M | 10.29% |
Dec 31, 2010 | 3.92B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Cencora | 276.54B |
Centene | 155.52B |
Takeda Pharmaceutical | 28.16B |
GE HealthCare Technologies | 19.50B |
Haleon | 14.31B |
Alcon | 9.56B |
Agilent Technologies | 6.59B |
Moderna | 5.15B |
IQV News
- 59 minutes ago - IQVIA Reports Second-Quarter 2024 Results - Business Wire
- 10 days ago - IQVIA Named a Leader in Medical Affairs and Regulatory Operations by Everest Group - Business Wire
- 13 days ago - IQVIA to Announce Second-Quarter 2024 Results on July 22, 2024 - Business Wire
- 26 days ago - IQVIA's SmartSolve® eQMS Wins 2024 MedTech Breakthrough Award “Best Use of Artificial Intelligence in Healthcare” - Business Wire
- 5 weeks ago - IQVIA Launches “One Home” Clinical Trial Technology Platform – Solves Challenges and Reduces Overload at Sites - Business Wire
- 5 weeks ago - IQVIA Institute: Innovative Therapies and Strong Pipeline to Combat Rise in Cancer Diagnoses - Business Wire
- 2 months ago - U.S. Medicines Spending Grew in 2023 as Greater Access Offset COVID-19-related Decline, Says IQVIA Institute - Business Wire
- 2 months ago - IQVIA CFO Ron Bruehlman to Speak at the Bank of America Health Care Conference on May 14, 2024 - Business Wire